Indications to revascularization in left main disease
Keywords:
left main disease, revascularization, PCI, CABGAbstract
Background and aim: Current guidelines recommend revascularization, either by coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), for patients with significant left main disease, especially when there is evidence of ischemia, left ventricular dysfunction, or high-risk anatomy
Methods: An extensive review of the literature was performed, including the most recent guidelines and relevant manuscript on left main revascularization treatment.
Results: CABG continues to be regarded as the gold standard, especially for individuals with complex coronary anatomy or impaired ventricular function. Conversely, PCI is considered a viable alternative in carefully selected patients who present with low-to-intermediate SYNTAX scores, favorable anatomical characteristics, and elevated surgical risk
Conclusions: Emerging evidence indicates that both CABG and PCI yield comparable early and long-term mortality outcomes. However, PCI is associated with increased rates of repeat revascularization and myocardial infarction over time, whereas CABG carries a higher early risk of stroke.
References
1. Collet C, Capodanno D, Onuma Y, et al. Left main coronary artery disease: pathophysiology, diagnosis, and treatment. Nat Rev Cardiol. 2018 Jun;15(6):321-33. doi: 10.1038/s41569-018-0001-4
2. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121: 2645–53. doi: 10.1161/CIRCULATIONAHA.109.899211
3. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011; 364: 1718–27. doi: 10.1056/NEJMoa1100452
4. Mäkikallio T, Holm NR, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743–52. doi: 10.1016/S0140-6736(16)32052-9
5. Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016; 375: 2223–35. doi: 10.1056/NEJMoa1610227
6. Patel N, De Maria GL, Kassimis G, et al. Outcomes after emergency percutaneous coronary intervention in patients with unprotected left main stem occlusion: the BCIS national audit of percutaneous coronary intervention 6-year experience. JACC Cardiovasc Interv. 2014;7(9):969-80. doi: 10.1016/j.jcin.2014.04.011
7. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:2574–2609. doi: 10.1161/CIR.0b013e31823a5596
8. Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009; 120(15):1505–1512. doi: 10.1161/CIRCULATIONAHA.109.850073
9. Mallidi J, Atreya AR, Cook J, et al. Long-term outcomes following fractional flow reserveguided treatment of angiographically ambiguous left main coronary artery disease: a meta-analysis of prospective cohort studies. Catheter Cardiovasc Interv. 2015; 86(1):12–18. doi: 10.1002/ccd.25894
10. Park SJ, Ahn JM, Kang SJ, et al. Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis. JACC Cardiovasc Interv. 2014;7(8):868-74. doi: 10.1016/j.jcin.2014.02.015
11. Bouki KP, Vlad DI, Goulas N, et al. Diagnostic Performance of Frequency-Domain Optical Coherence Tomography to Predict Functionally Significant Left Main Coronary Artery Stenosis. J Interv Cardiol. 2021;2021:7108284. doi: 10.1155/2021/7108284
12. Byrne RA, Rossello X, Coughlan JJ et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024;13(1):55-161. doi: 10.1093/eurheartj/ehad191
13. Sabatine MS, Bergmark BA, Murphy SA, et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. Lancet 2021;398:2247–57. doi: 10.1016/S0140-6736(21)02334-5
14. Huckaby LV, Sultan I, Ferdinand FD, et al. Matched Analysis of Surgical Versus Percutaneous Revascularization for Left Main Coronary Disease. Ann Thorac Surg. 2022;113(3):800-807. doi: 10.1016/j.athoracsur.2021.04.043
15. Tam DY, Fang J, Rocha RV, et al. Real-World Examination of Revascularization Strategies for Left Main Coronary Disease in Ontario, Canada. JACC Cardiovasc Interv. 2023;16(3):277-288. doi: 10.1016/j.jcin.2022.10.016
16. Byrne RA, Fremes S, Capodanno D, et al. 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. Eur J Cardiothorac Surg. 2023;64(2):ezad286. doi: 10.1093/ejcts/ezad286
17. Kandzari DE, Gershlick AH, Serruys PW, et al. Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2018;11(10):e007007. doi: 10.1161/CIRCINTERVENTIONS.118.007007
18. Choi KH, Song YB, Lee JM, et al. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent. Circ Cardiovasc Interv. 2020;13(2):e008543. doi: 10.1161/CIRCINTERVENTIONS.119.008543
19. Kinnaird T, Gallagher S, Anderson R, et al. Are Higher Operator Volumes for Unprotected Left Main Stem Percutaneous Coronary Intervention Associated With Improved Patient Outcomes?: A Survival Analysis of 6724 Procedures From the British Cardiovascular Intervention Society National Database. Circ Cardiovasc Interv. 2020;13(6):e008782. doi: 10.1161/CIRCINTERVENTIONS.119.008782
20. Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Federico Giorgi, Andrea Colli, Francesco Nicolini, Davide Carino
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
